BCWORLD PHARM. Co. Ltd (200780) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.020x

Based on the latest financial reports, BCWORLD PHARM. Co. Ltd (200780) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.43 Billion ≈ $968.52K USD) by net assets (₩72.50 Billion ≈ $49.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 200780 net asset quality score to measure how much of total assets are equity-financed.

BCWORLD PHARM. Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how BCWORLD PHARM. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BCWORLD PHARM. Co. Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

BCWORLD PHARM. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BCWORLD PHARM. Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Digital Currency X Technology Inc. NASDAQ:DCX	-0.005x
Studio Mir Co. Ltd. KQ:408900	-0.036x
New York City REIT Inc NYSE:NYC	-0.046x
Kobexindo Tractors Tbk JK:KOBX	0.622x
ISE Commerce Company Limited KQ:069920	-0.014x
Vunani Ltd JSE:VUN	0.145x
Reitmans Canada Ltd V:RET	0.172x
Eagon Holdings Co.Ltd KQ:039020	0.005x

Annual Cash Flow Conversion Efficiency for BCWORLD PHARM. Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of BCWORLD PHARM. Co. Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see BCWORLD PHARM. Co. Ltd (200780) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩76.67 Billion ≈ $51.96 Million	₩4.04 Billion ≈ $2.74 Million	0.053x	-60.64%
2023-12-31	₩81.64 Billion ≈ $55.33 Million	₩10.94 Billion ≈ $7.41 Million	0.134x	+54.84%
2022-12-31	₩79.55 Billion ≈ $53.91 Million	₩6.88 Billion ≈ $4.66 Million	0.087x	+1237.07%
2021-12-31	₩81.46 Billion ≈ $55.20 Million	₩-619.83 Million ≈ $-420.05K	-0.008x	+85.94%
2020-12-31	₩101.69 Billion ≈ $68.92 Million	₩-5.50 Billion ≈ $-3.73 Million	-0.054x	-143.45%
2019-12-31	₩97.24 Billion ≈ $65.90 Million	₩12.11 Billion ≈ $8.21 Million	0.125x	+110.10%
2018-12-31	₩90.09 Billion ≈ $61.05 Million	₩5.34 Billion ≈ $3.62 Million	0.059x	-39.05%
2017-12-31	₩81.23 Billion ≈ $55.05 Million	₩7.90 Billion ≈ $5.35 Million	0.097x	+2848.61%
2016-12-31	₩73.88 Billion ≈ $50.06 Million	₩243.66 Million ≈ $165.13K	0.003x	-97.47%
2015-12-31	₩67.40 Billion ≈ $45.68 Million	₩8.78 Billion ≈ $5.95 Million	0.130x	--

About BCWORLD PHARM. Co. Ltd

KQ:200780 Korea Drug Manufacturers - General

Market Cap

$21.41 Million

₩31.59 Billion KRW

Market Cap Rank

#24831 Global

#1779 in Korea

Share Price

₩3090.00

Change (1 day)

+3.00%

52-Week Range

₩2960.00 - ₩5870.00

All Time High

₩30700.49